Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel

The Journal of Pharmacology and Experimental Therapeutics
Sharon L HaleRobert A Kloner

Abstract

Ranolazine is an inhibitor of the late sodium current and, via this mechanism, decreases sodium-dependent intracellular calcium overload during ischemia and reperfusion. Ranolazine reduces angina, but there is little information on its effects in acute myocardial infarction. The aim of this study was to test the effects of ranolazine on left ventricular (LV) function and myocardial infarct size after ischemia/reperfusion in rabbits. Ten minutes before coronary artery occlusion (CAO), anesthetized rabbits were assigned to vehicle (n=15) or ranolazine (2 mg/kg i.v. bolus plus 60 microg/kg/min i.v. infusion; n=15). Hearts received 60 min of CAO and 3 h of reperfusion. CAO caused LV dysfunction associated with necrosis. However, at the end of reperfusion, rabbits treated with ranolazine had better global LV ejection fraction (0.42+/-0.02 versus 0.33+/-0.02; p<0.007) and stroke volume (1.05+/-0.08 versus 0.78+/-0.07 ml; p<0.01) compared with vehicle. The fraction of the LV wall that was akinetic or dyskinetic was significantly less in the ranolazine group at 0.23+/-0.03 versus 0.34+/-0.03 in vehicle-treated group; p<0.02. The ischemic risk region was similar in both groups; however, infarct size was significantly smaller in the trea...Continue Reading

References

Dec 1, 1994·Journal of Cardiovascular Pharmacology·S C BlackB R Lucchesi
Aug 1, 1994·Cardiovascular Research·M R GralinskiB R Lucchesi
May 1, 1997·The Journal of Physiology·C A Ward, W R Giles
Mar 10, 1999·Cardiovascular Research·S L Hale, R A Kloner
Jun 26, 1999·Circulation Research·E MurphyC Steenbergen
Mar 26, 2003·Cardiovascular Research·Burkert PieskeDonald M Bers
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Bernard R ChaitmanUNKNOWN Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators
Apr 20, 2004·Journal of the American College of Cardiology·Bernard R ChaitmanUNKNOWN MARISA Investigators
Jul 10, 2004·Journal of Cardiovascular Pharmacology·Yejia SongLuiz Belardinelli
Jan 27, 2005·The American Journal of Cardiology·Michel F RousseauAndrew A Wolff
Mar 8, 2006·British Journal of Pharmacology·Sandra FredjRobert S Kass

❮ Previous
Next ❯

Citations

Aug 18, 2006·Basic Research in Cardiology·Thorsten Reffelmann, Robert A Kloner
Jul 28, 2007·Basic Research in Cardiology·Christoph Maack, Brian O'Rourke
May 8, 2010·Advances in Therapy·Sajid Aslam, David Gray
Mar 25, 2011·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Rajesh VenkataramanAmi E Iskandrian
Oct 16, 2012·Circulation Research·Andrew M WaltersPaul S Brookes
Aug 30, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Masaki YamamotoShiro Sasaguri
Jun 30, 2011·Der Internist·T Meinertz, R Köster
Jun 7, 2013·Basic Research in Cardiology·Alexander NickelChristoph Maack
Aug 14, 2012·The American Journal of Cardiology·Rajesh VenkataramanAmi E Iskandrian
Jul 18, 2015·Revista Española De Cardiología·Eva M Calderón-SánchezAntonio Ordóñez
Nov 26, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Tuomo NieminenRichard L Verrier
May 9, 2008·Journal of Molecular and Cellular Cardiology·Sharon L HaleRobert A Kloner
Dec 12, 2007·British Journal of Pharmacology·D A Saint
Feb 20, 2007·The Annals of Thoracic Surgery·Peipei WangWilliam Holman
Nov 17, 2009·JACC. Cardiovascular Imaging·Rajesh VenkataramanAmi E Iskandrian
Sep 11, 2010·Journal of the American College of Cardiology·Peter H StoneGary G Koch
Sep 11, 2010·Journal of the American College of Cardiology·William E Boden
Apr 28, 2016·Future Cardiology·David E KrummenAmir A Schricker
Aug 6, 2016·European Journal of Pharmacology·Panagiotis EfentakisEfstathios K Iliodromitis
Jan 20, 2017·Basic Research in Cardiology·Carlotta RonchiAntonio Zaza
Jan 16, 2007·Journal of Cardiovascular Pharmacology and Therapeutics·Sharon L Hale, Robert A Kloner
Mar 31, 2009·Journal of Cardiovascular Pharmacology and Therapeutics·Hyosook HwangRobert A Kloner
Jun 23, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Taylor HowardThomas J Hund
Feb 9, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Daniel J ConklinAruni Bhatnagar
Jan 21, 2010·Physiological Reviews·Gary D LopaschukWilliam C Stanley
Mar 13, 2010·Expert Review of Cardiovascular Therapy·Thorsten Reffelmann, Robert A Kloner
Jun 28, 2019·Journal of Cardiovascular Pharmacology and Therapeutics·Vassileios MoschovidisIsaac Aidonidis
May 22, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Tetsuji MiuraKazuaki Shimamoto
Dec 10, 2014·Journal of Cardiovascular Pharmacology·Sandra GhelardoniRiccardo Zucchi
Jun 26, 2018·Journal of Cardiovascular Pharmacology and Therapeutics·Tjark F SchwemerFelix W Friedrich
Nov 27, 2007·Expert Review of Cardiovascular Therapy·Wei Wang, Gary D Lopaschuk
Sep 22, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Arvinder K DhallaRobert A Kloner
Dec 2, 2020·Channels·Kornél KistamásPéter P Nánási

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.